Introduction
============

Endodontic treatment of traumatized immature permanent necrotic teeth is a clinical challenge. Among different treatment protocols, regenerative endodontic procedures (REPs) that are defined as "biologically based" treatments seem to offer a better outcome in terms of tooth development and survival. [@JR_1] [@JR_2] Induced bleeding in REPs provides a source of stem cells that may originate from the apical papilla and play an important role in forming the desired tissues. [@JR_3] Given that in these procedures root canal debridement is mainly provided by chemical disinfection rather than mechanical instrumentation, it is important to maintain a balance between antibacterial effectiveness of the chemicals and their innocuousness for stem cells. [@JR_4] [@JR_5]

Calcium hydroxide \[Ca(OH) ~2~ \] has been used as an antibacterial agent in regenerative endodontics. [@JR_6] [@JR_7] Due to certain disadvantages, antibiotics seemed to be an appropriate alternative. [@JR_8] Different antibiotic mixtures such as triple antibiotic paste (TAP: Metronidazole, Minocycline and ciprofloxacin), double antibiotic paste (DAP: metronidazole and ciprofloxacin), and modified triple antibiotic paste (MTAP: minocycline component replaced) have been used. [@JR_9] [@JR_10] In a few studies, Augmentin has also been reported as an effective antibacterial agent in regenerative endodontics [@JR_11] [@JR_12] and maybe useful in case of no allergy to penicillin. Concerns still remain in terms of tooth discoloration [@JR_13] and adverse effect of high concentrations of antibiotics on stem cell integrity. [@JR_12] [@JR_14] [@JR_15]

Still, there is little reliable information about the most effective intracanal disinfecting agent or the best concentration of available drugs that could provide maximum antimicrobial efficacy along with minimal damage to the viability and function of stem cells. [@JR_16]

Two aims were pursued in this *in vitro* study: first, to determine the minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum biofilm inhibitory concentration (MBIC) of Ca(OH) ~2~ , TAP, DAP, MTAP (minocycline replaced by clindamycin) and Augmentin against *Enterococcus faecalis* (ATCC 29212) using microtiter plate method and second, to evaluate the cytotoxic effect of mentioned concentrations of intracanal medicaments on stem cells of apical papilla (SCAP) using lactate dehydrogenase (LDH) and water-soluble tetrazolium salt (WST-1) assays. As we know, this is the first study that investigates the cytotoxicity of minimum inhibitory values of drugs using *Enterococcus faecalis* (ATCC 29212) on the SCAP. [@JR_17] [@JR_18]

Reports are also available about antibacterial effectiveness of TAP, DAP, and Ca(OH) ~2~ . [@JR_18] To the best of our knowledge, there is no report about MIC, MBC, and MBIC measurement of the modified triple antibiotic mixtures that have incorporated clindamycin instead of minocycline.

Materials and Methods
=====================

Primary Cell Culture
--------------------

SCAP were obtained from intact immature mandibular third molars of a patient by enzymatic digestion method. [@JR_19] Informed consent was obtained and all procedures were approved by the human experimental committee of dental school of Tehran University of medical sciences, Tehran, Iran (IR.TUMS.DENTISTRY.REC.1396.2813).

The cells were cultured in Dulbecco's modified eagle's medium (DMEM) (Gibco; Carlsbad, California, United States) supplemented with 10% fetal bovine serum, 1× L-glutamine, penicillin (100 U/mL), and streptomycin (100 U/mL) and then grown to 70 to 80% confluency. SCAP after third and fourth passages, were harvested and used in this study.

Medicament Preparation
----------------------

A 10 mg/mL dilution of TAP ( *metronidazole, ciprofloxacin, and minocycline),* MTAP ( *metronidazole, ciprofloxacin, and clindamycin* ) and DAP *(metronidazole, ciprofloxacin* ) were prepared by dissolving equal portions of USP (United States Pharmacopeia)-grade antibiotic powders (Sigma-Aldrich Chemie GmbH, Germany) in distilled water to prepare stock solutions. The dilution of stock solution was defined based on previous studies and a pilot study that determined MBIC measurements.

For preparing TAP and MTAP, 16.5 mg and for DAP, 25 mg of each antibiotic was used and the powder mixture was dissolved in 5 mL distilled water.

For Augmentin a 10 mg/mL stock solution was prepared by dissolving 10 mg of drug in 1 mL distilled water. Ca(OH) ~2~ solution was prepared by stirring 16 mg of Ca(OH) ~2~ powder (Golchaico, Ir) in 1 mL of distilled water, according to Sabrah et al. [@JR_18]

MIC, MBC, and MBIC Determination
--------------------------------

*Enterococcus faecalis* (ATCC 29212) was used as the standard bacterial strain to define antimicrobial efficacy of drugs. It is the most suitable strain for determining MIC of medicaments using dilution methods, according to CLSI guideline. [@BR_20]

Minimum inhibitory concentration, which is the lowest concentration of a chemical which prevents visible growth of a bacterium, [@JR_21] was determined by a two-fold dilution method. [@JR_18]

Minimum bactericidal concentration is the lowest concentration of an antibacterial agent required to kill a particular bacterium. [@JR_18] [@JR_21] To determine MBC, samples were taken from the wells of test drugs, at concentrations equal to and higher than MIC, and subcultured on brain heart agar plates and incubated for 24 hours. MBC was represented as no bacterial growth on agar plates during the aforementioned time. [@JR_18]

Minimum biofilm inhibitory concentration, which is the lowest concentration of an agent that inhibits the visible biofilm formation of a microorganism, [@JR_22] was determined by microtiter plate method. [@JR_18]

LDH Assays
----------

Subconfluent SCAP were seeded into a 96-well plate (10,000 cells/well) and incubated for 24 hours in DMEM supplemented with 10% fetal bovine serum, to allow the cells to attach. After 24 hours, the old medium was removed, and the cells were incubated with serum-free DMEM in the presence of MIC, MBC, and MBIC of test drugs for 3 days. SCAP incubated without any medicament in serum-free DMEM were used as negative control (low control), and SCAP incubated with lysis solution were used as positive control (high control). After the mentioned time, supernatants were collected and utilized for LDH assay. The levels of LDH, released by the cells into the medium due to membrane damage, were determined by Takara LDH Cytotoxicity Detection Kit (MK401; Takara, Japan). Briefly, 100 µL of SCAP culture media were transferred into another 96-well plate. Then 100 µL of reaction mixture, prepared according to manufacturer protocol, was added and mixed in each well and the plate was incubated for 30 minutes at room temperature. BioTek microplate reader (BioTek Instruments, Inc. Winooski, VT, United States) was used to quantitatively measure the calorimetric change at a wavelength of 490 nm. The following equation was used to calculate the percentage of cytotoxicity:

Cytotoxicity (%) = (experimental value-low control)/ (high control-low control) ×100

The high control cytotoxicity percentage was considered to be 100%; while the low control was 0% ( [Supplementary Table 1](#SM90051-001){ref-type="supplementary-material"} , available in online version only).

WST-1 Assays
------------

WST-1 assay (PreMix WST-1 Cell Proliferation Assay system; MK400, Takara, Japan) was used to measure mitochondrial dehydrogenase activity of treated and nontreated SCAP. Treated SCAP were exposed to certain defined concentrations of different test drugs and fulfilled 3 days of incubation; while untreated SCAP, which were considered as control group, had no drug exposure. After collecting the medium for the LDH assay and washing the cells with phosphate buffer solution, 20 µL of PreMix WST-1 solution and serum-free DMEM was added to SCAP to maintain a final dilution of 1:10. Then, cells were incubated at 37 C in a humidified atmosphere containing 5% CO [@JR_2] for 4 hours. Ultimately, BioTek microplate reader (BioTek, United States) was used to measure the optical absorbance of each well at 420 nm. The following equation was used to calculate the percentage of cell viability.

Cell viability (%) = (absorbance value of the treated cells/absorbance value of untreated cells) ×100

The viability percentage of the untreated cells was considered 100% ( [Supplementary Table 1](#SM90051-001){ref-type="supplementary-material"} , available in online version only).

Comparisons were made using one-way analysis of variance (ANOVA) and post hoc tests (Tukey and Games-Howell). The statistical power was set at *p* \< 0.05.

Results
=======

MIC, MBC, and MBIC of tested medicaments are shown in [Table 1](#TB_1){ref-type="table"} .

###### MIC, MBC, and MBIC of tested drugs in mg/mL

  Test drugs   Concentrations (mg/mL)             
  ------------ ------------------------ --------- -----------------
  TAP          0.00006                  0.00195   0.00195
  DAP          0.007                    0.031     0.156
  MTAP         0.000976                 0.00781   0.25
  Augmentin    0.000976                 0.00195   0.00195
  Ca(OH) ~2~   0.2                      16        Not defined ^a^

Based on the results of LDH assay, all the tested concentrations of medicaments were significantly less toxic than the high control sample ( *p* \< 0.001), with the exception of MBC of Ca(OH) ~2~ ( *p* \> 0.05) ( [Fig. 1](#FI90051-1){ref-type="fig"} ) ( **[Supplementary Table 2](#SM90051-001){ref-type="supplementary-material"}** , available in online version only).

![Cytotoxicity (%) of the tested medicaments at MIC, MBC, and MBIC. \*\* denotes a significant difference relative to the high control ( *p* \< 0.001). DAP, double antibiotic paste; MBC, minimum bactericidal concentration; MBIC, minimum biofilm inhibitory concentration; MIC, minimum inhibitory concentration; TAP, triple antibiotic paste.](10-1055-s-0039-3401369_90051_01){#FI90051-1}

According to WST-1 assay, with increasing drug concentration cell viability showed a decreasing trend, except for TAP and DAP. Reduced cell viability was statistically significant at MBC and MBIC of Augmentin compared with TAP and DAP ( *p* \< 0.05) and also at MBC of Ca(OH) ~2~ compared with TAP, DAP, and MTAP ( *p* \< 0.001). Increased concentration of TAP and DAP could not adversely affect cell viability ( *p* \> 0.05) ( [Fig. 2](#FI90051-2){ref-type="fig"} ) ( [Supplementary Table 2](#SM90051-001){ref-type="supplementary-material"} ; available in online version only).

![Cell viability (%) related to MIC, MBC, and MBIC of the tested medicaments. \*\*denotes a significant difference relative to control ( *p* \< 0.001). \* denotes a significant difference relative to control ( *p* \< 0.05). DAP, double antibiotic paste; MBC, minimum bactericidal concentration; MBIC, minimum biofilm inhibitory concentration; MIC, minimum inhibitory concentration; DAP, double antibiotic paste; TAP, triple antibiotic paste.](10-1055-s-0039-3401369_90051_02){#FI90051-2}

LDH assay evaluation of the tested drugs presented higher cytotoxicity of Augmentin at its MIC in comparison with other medicaments ( *p* \< 0.05) ( [Fig. 3](#FI90051-3){ref-type="fig"} ). Cytotoxic effect of TAP, DAP, MTAP, and Ca(OH) ~2~ was similar at MIC ( *p* \> 0.05). Comparing the toxicity of drugs at MBC revealed a significantly higher cytotoxicity of Ca(OH) ~2~ than the other medicaments ( *p* \< 0.001), while others caused similar results ( *p* \> 0.05). At MBIC, Augmentin was significantly more cytotoxic than TAP and DAP ( *p* \< 0.05). TAP and DAP had similar cytotoxic effects at this concentration ( *p* \> 0.05) ( [Fig. 3](#FI90051-3){ref-type="fig"} ) ( [Supplementary Table 2](#SM90051-001){ref-type="supplementary-material"} ; available in online version only).

![Comparison of cytotoxicity (%) induced by MIC, MBC, and MBIC of the tested medicaments. DAP, double antibiotic paste; MBC, minimum bactericidal concentration; MBIC, minimum biofilm inhibitory concentration; MIC, minimum inhibitory concentration; DAP, double antibiotic paste; TAP, triple antibiotic paste.](10-1055-s-0039-3401369_90051_03){#FI90051-3}

According to WST-1, the lowest proliferation rate at MIC value was also attributed to Augmentin that was significantly lower than most of the other drugs ( *p* \< 0.05) ( [Fig. 4](#FI90051-4){ref-type="fig"} ). At this concentration, TAP could cause a notable proliferation rate that was significantly higher than DAP ( *p* \< 0.05). Checking MBC value indicated that the least proliferation rate was related to Ca(OH) ~2~ ( *p* \< 0.001) followed by Augmentin ( *p* \< 0.05). TAP caused a superior cell proliferation in comparison with other medicaments at MBC ( *p* ≤ 0.001), but there was no significant difference between TAP and DAP in this regard ( *p* \> 0.05) ( [Supplementary Table 2](#SM90051-001){ref-type="supplementary-material"} ; available in online version only).

![Comparison of cell viability (%) related to MIC, MBC, and MBIC of the tested medicaments. MBC, minimum bactericidal concentration; MBIC, minimum biofilm inhibitory concentration; MIC, minimum inhibitory concentration; DAP, double antibiotic paste; TAP, triple antibiotic paste.](10-1055-s-0039-3401369_90051_04){#FI90051-4}

At MBIC, again TAP caused a significantly superior proliferation rate in comparison with other drugs ( *p* \< 0.001) except DAP ( *p* \> 0.05). DAP could also cause significantly higher proliferation rate than other drugs ( *p* \< 0.05). Both Augmentin and MTAP represented the same adverse effect on cell proliferation ( *p* \> 0.05) ( [Fig. 4](#FI90051-4){ref-type="fig"} ) ( [Supplementary Table 2](#SM90051-001){ref-type="supplementary-material"} ; available in online version only).

Discussion
==========

Providing a microbe free environment by means of medicaments that would cause the least toxic effect on stem cells is mandatory for the regeneration of dentin--pulp complex. [@JR_23] Attempts to select a suitable medicament are still ongoing and different dilutions have been studied for cytotoxicity and antibacterial effect. [@JR_12] [@JR_14] [@JR_15] [@JR_24] [@JR_25] Unlike previous studies, this study aimed to consider the cytotoxic effect of "minimum antimicrobial inhibitory dilutions" of different medicaments on the stem cells.

Concerns about the safety of stem cells have led to the tendency of using lesser concentrations of intracanal medicaments. [@JR_12] [@JR_25] Since low doses of antibiotics have been utilized in manufacturing some antibiotic releasing scaffolds, [@JR_26] [@JR_27] [@JR_28] and because of the desirability of slow release of low doses of medicaments from these scaffolds, it is important to investigate toxicity of the low concentrations of antibiotics on different kinds of stem cells as well as their antibacterial effectiveness against different bacterial species and biofilms that may help in the technology of manufacturing scaffolds.

For toxicity evaluation, different methods have been used so far. [@JR_12] [@JR_14] [@JR_15] [@JR_24] In the category of spectrophotometry, both LDH and WST-1 assays are widely used for cell death studies. [@JR_29] LDH assay is related to the cell death, while WST-1 assay reflects the mitochondrial metabolism and rather demonstrates the viability of cells. To overcome the shortcomings of these tests, it is recommended to incorporate their results to derive more reliable knowledge of cell cytotoxicity and proliferation. [@JR_15] [@JR_29] [@JR_30]

In the current study, the tested concentrations of intracanal medicaments were very low and according to the LDH assay, minimally toxic and nonlethal ( [Fig. 1](#FI90051-1){ref-type="fig"} ). However, it is possible to detect changes in mitochondrial activity level before cell membrane degradation and LDH release using WST-1 assay. Considering the findings of WST-1 assay, it seems that even low concentrations of chemicals might have caused some cellular damage not necessarily leading to death but affecting cells function and behavior ( [Fig. 2](#FI90051-2){ref-type="fig"} ). Thus, WST-1 assay may be more illustrative when the effects of low concentrations of medicaments on the function of stem cells are to be investigated. Similar observations have been reported by other researchers, such as Labban et al [@JR_15] and Sabrah et al. [@JR_24] ^.^

In accordance with current findings, many studies have confirmed reduced cytotoxicity of medicaments in lower concentrations. [@JR_12] [@JR_14] [@JR_15] [@JR_24] [@JR_25] [@JR_31] Although the results may not be completely comparable to the current study because of differences in methods and materials.

One of the noticeable findings of the current study is the promotive effect of TAP on SCAP proliferation at all the tested concentrations. This may suggest a positive effect of some medicaments while diluted by body fluids which is in accordance with the findings of Labban et al. [@JR_15] DAP behaved similarly in terms of cell toxicity in range of tested concentrations. This finding may suggest similar behavior of diluted antibiotics, while they may have different effects at higher concentrations.

In this study, the amount of Ca(OH) ~2~ for preparing stock solution was selected due to Sabrah's study. [@JR_18]

In contrast to Sabrah et al [@JR_18] in this study only MIC and MBC values could be measured for Ca(OH) ~2~ . However, to achieve MBC, a prominent increase in the drug concentration was necessary. This difference might be related to the different commercial compositions used. It was not possible to measure MBIC of Ca(OH) ~2~ , because it was incapable of preventing biofilm formation even at the highest concentration that could be practically drawn up into the pipette. It is noteworthy that the MIC of Ca(OH) ~2~ caused a significant increase in cell proliferation in comparison to the control group. This favorable effect was not achieved by higher concentrations of this medicament. This finding was in accordance with Labban et al, who reported that 2.5 mg/mL of Ca(OH) ~2~ was the highest nontoxic concentration. [@JR_15] They had discussed that some drugs may have a positive effect on cell growth and proliferation at low-concentration while exhibiting toxic effect at higher concentrations. [@JR_15]

This finding is also reported by Alghilan et al [@JR_31] and Hosseini Matin et al [@JR_32] who did not support using the higher concentrations of Ca(OH) ~2~ , while others like Ruparel et al [@JR_12] and Althumairy et al [@JR_14] found Ca(OH) ~2~ to be safe enough even in high concentrations.

Based on the current study, using Ca(OH) ~2~ in dilutions less than pasty consistency may provide better results in term of cell viability.

On the other hand, current study supports the idea that some antibacterial medicaments may represent their acceptable antibacterial efficacy at higher concentrations that maybe harmful for the viability and function of stem cells. If proved in further studies, the use of some medications may be revised in future endodontic regenerative protocols.

Although the amount of antibacterial inhibitory concentrations of Augmentin was much lower than some other medicaments such as Ca(OH) ~2~ and MTAP, these values imposed a considerable adverse effect on SCAP. This finding may suggest that the cytotoxicity of certain chemicals depends on their inherent properties, rather than due to the increase in their concentration.

In this study, the unfavorable effect of low concentrations of Augmentin on SCAP suggests the need for further studies before recommending this drug as an antibacterial medicament in REPs.

This study suggests that effective antibacterial concentrations of intracanal medicaments used in REPs may have different effects on the integrity of stem cells. TAP was well tolerated by SCAP; Augmentin and high concentrations of Ca(OH) ~2~ revealed some adverse effects at their effective antimicrobial values. This idea has to be further tested in other preclinical studies using a range of bacterial species. In addition, proper antimicrobial effectiveness of the mentioned concentrations must be confirmed on polymicrobial flora of irregular root canal space of infected immature permanent teeth in clinical studies with higher level of evidence.
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